(30 days)
Not Found
No
The description focuses on the mechanical aspects of the device (metallic clip, introducer, deployment handle) and its intended uses for tissue approximation and hemostasis. There is no mention of any software, algorithms, or data processing that would suggest the use of AI or ML. The performance studies described are bench tests related to mechanical deployment, not algorithmic performance.
Yes
The device is used for medical purposes such as hemostasis, closure of perforations, and anchoring, which directly address a health condition or restore normal function.
No
The device description and intended use indicate it is used for therapeutic procedures like hemostasis, marking, and closure, not for diagnosing conditions.
No
The device description clearly details a physical, sterile, single-use metallic clip preloaded on a physical introducer with a handle, designed for insertion through an endoscope. This is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device used for direct intervention within the body (endoscopic clip placement in the gastrointestinal tract) for purposes like hemostasis, marking, anchoring, and closure of perforations.
- Device Description: The description details a physical clip and its delivery system, designed for mechanical action on tissue.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue samples) to provide information for diagnosis, monitoring, or screening.
IVD devices are used outside the body to analyze samples and provide diagnostic information. This device is used inside the body for therapeutic and procedural purposes.
N/A
Intended Use / Indications for Use
This device is used for endoscopic clip placement within the gastrointestinal tract for the purpose of: 1. Endoscopic marking. - 2. Hemostasis for - · Mucosal/submucosal defects less than 3 cm, - · Bleeding ulcers, - · Arteries less than 2 mm. - · Polyps less than 1.5 cm in diameter, - · Diverticula in the colon, and - · Prophylactic clipping to reduce the risk of delayed bleeding post lesion resection, - 3. Anchoring to affix jejunal feeding tubes to the wall of the small bowel, 4. As a supplementary method for closure of GI tract luminal perforations less than 20 mm that can be treated conservatively. 5. Anchoring to affix fully covered esophageal self-expanding metal stents to the wall of the esophagus in patients with fistulas, leaks, perforations, or disunion.
Product codes
PKL
Device Description
The Instinct Plus Endoscopic Clipping Device is a sterile, single use metallic clip used for tissue approximation and hemostasis in the gastrointestinal tract. The metallic clip is 14.4 mm long and has an opening span of 16 mm. The clip is preloaded on a 230 cm long introducer comprised of a coated coil spring, drive wire and deployment handle. The clip may be deployed to the site of interest using a straight viewing flexible endoscope with a minimum accessory channel of 2.8 mm, or side viewing flexible endoscope with a minimum accessory channel of 4.2 mm. The clip can be rotated for positioning by rotating the handle of the introducer and may be reopened and closed up to five times prior to deployment. The Instinct Plus Endoscopic Clipping Device is supplied sterilized by ethylene oxide gas in a peel-open package and intended for one-time use. The product is packaged with three-year shelf life.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
gastrointestinal tract, small bowel, esophagus
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Baseline testing consisting of non-clinical bench testing demonstrates that the Instinct Plus Endoscopic Clipping Device enabled consistent deployment of the clip to fulfill the intended use of the device. Validation testing was repeated to deploy devices without tissue to simulate worst case. Validation testing was also repeated utilizing process data to confirm the Strength of Distal Coil Cath Tabs met acceptance criteria. Testing passed demonstrating the device is substantially equivalent to the currently cleared predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.4400 Hemorrhoidal ligator.
(a)
Identification. A hemorrhoidal ligator is a device used to cut off the blood flow to hemorrhoidal tissue by means of a ligature or band placed around the hemorrhoid.(b)
Classification. Class II (special controls). Except for a hemostatic metal clip intended for use in the gastrointestinal tract, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
August 25, 2021
Wilson-Cook Medical Inc. Scottie Fariole Regulatory Science Specialist 4900 Bethania Station Road Winston-Salem, NC 27105
Re: K212323
Trade/Device Name: Instinct Plus Endoscopic Clipping Device Regulation Number: 21 CFR 876.4400 Regulation Name: Hemorrhoidal ligator Regulatory Class: Class II Product Code: PKL Dated: July 23, 2021 Received: July 26, 2021
Dear Scottie Fariole:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general control's provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for
Shanil P. Haugen, Ph.D. Assistant Director DHT3A: Division of Renal, Gastrointestinal, Obesity and Transplant Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
Submission Number (if known)
Device Name
Instinct Plus Endoscopic Clipping Device
Indications for Use (Describe)
This device is used for endoscopic clip placement within the gastrointestinal tract for the purpose of: 1. Endoscopic marking.
-
- Hemostasis for
- · Mucosal/submucosal defects less than 3 cm,
- · Bleeding ulcers,
- · Arteries less than 2 mm.
- · Polyps less than 1.5 cm in diameter,
- · Diverticula in the colon, and
- · Prophylactic clipping to reduce the risk of delayed bleeding post lesion resection,
-
- Anchoring to affix jejunal feeding tubes to the wall of the small bowel,
-
As a supplementary method for closure of GI tract luminal perforations less than 20 mm that can be treated conservatively.
-
Anchoring to affix fully covered esophageal self-expanding metal stents to the wall of the esophagus in patients with fistulas, leaks, perforations, or disunion.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
COOK®
MEDICAL
COOK ENDOSCOPY 4900 BETHANIA STATION ROAD WINSTON-SALEM, NC 27105 U.S.A. PHONE: 336.744.0157 TOLL FREE: 800.245.4707 WWW.COOKMEDICAL.COM
510(k) Summary Name: Wilson-Cook Medical, Inc. /Cook Endoscopy Address: 4900 Bethania Station Road Winston-Salem, North Carolina 27105 Phone: (336)744-0157 Fax: (336)201-5994 Contact: Scottie Fariole, Regulatory Science Specialist Date: August 25, 2021 Device Name: Instinct Plus Endoscopic Clipping Device Common Name: Hemostatic Metal Clip For The Gi Tract or Endoscopic Clipping Device Classification Name: Hemorrhoidal Ligator (21 CFR 876.4400, Product Code PKL) Product Code Name: Hemostatic Metal Clip For The Gi Tract Regulatory Class: Class II Device Predicate Instinct Plus Endoscopic Clipping Device (K192697) Device: Description of the The Instinct Plus Endoscopic Clipping Device is a sterile, single Device: use metallic clip used for tissue approximation and hemostasis in the gastrointestinal tract. The metallic clip is 14.4 mm long and has an opening span of 16 mm. The clip is preloaded on a 230 cm long introducer comprised of a coated coil spring, drive wire and deployment handle. The clip may be deployed to the site of interest using a straight viewing flexible endoscope with a minimum accessory channel of 2.8 mm, or side viewing flexible endoscope with a minimum accessory channel of 4.2 mm. The clip can be rotated for positioning by rotating the handle of the introducer and may be reopened
Page 1 of 4
life.
and closed up to five times prior to deployment. The Instinct Plus Endoscopic Clipping Device is supplied sterilized by ethylene oxide gas in a peel-open package and intended for one-time use. The product is packaged with three-year shelf
4
Cook Endoscopy - Special 510(k) Instinct Plus Endoscopic Clipping Device
Intended Use: This device is used for endoscopic clip placement within the gastrointestinal tract for the purpose of: 1. Endoscopic marking, 2. Hemostasis for • Mucosal/submucosal defects less than 3 cm, • Bleeding ulcers, · Arteries less than 2 mm, • Polyps less than 1.5 cm in diameter, • Diverticula in the colon, and • Prophylactic clipping to reduce the risk of delayed bleeding post lesion resection, 3. Anchoring to affix jejunal feeding tubes to the wall of the small bowel, 4. As a supplementary method for closure of GI tract luminal perforations less than 20 mm that can be treated conservatively, 5. Anchoring to affix fully covered esophageal self-expanding metal stents to the wall of the esophagus in patients with fistulas, leaks, perforations, or disunion. Technological The subject Instinct Plus Endoscopic Clipping Device is Characteristics: substantially equivalent to the referenced Instinct Plus Endoscopic Clipping Device (K192697) with respect to Indications for Use, Principles of Operation and overall device design, dimensions, shape and material. The change that is the subject of this 510(k) is to tighten the dimensional specification and tolerance on the proximal end of the catheter attach component of the introducer. The purpose of the change is to improve deployment consistency and address events related to inability to deploy clip observed in clinical use. A comparison of the key feature of the subject device and predicate device is included in the Substantial Equivalence Comparison table.
Summary Substantial Equivalence Comparison Table:
| Parameter | Instinct Plus Endoscopic
Clipping Device (Subject
Device) | Instinct Plus Endoscopic
Clipping Device (K192697) | Comparison |
|----------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for
Use | This device is used for
endoscopic clip placement
within the gastrointestinal
tract for the purpose of
- Endoscopic marking,
- Hemostasis for
• Mucosal/submucosal
defects less than 3 cm
• Bleeding ulcers, | This device is used for
endoscopic clip placement
within the gastrointestinal
tract for the purpose of - Endoscopic marking,
- Hemostasis for
• Mucosal/submucosal
defects less than 3 cm
• Bleeding ulcers, | Identical |
| Parameter | Instinct Plus Endoscopic
Clipping Device (Subject
Device) | Instinct Plus Endoscopic
Clipping Device (K192697) | Comparison |
| | | | |
| | • Arteries less than 2 mm,
• Polyps less than 1.5 cm
in diameter,
• Diverticula in the colon,
and
• Prophylactic clipping to
reduce the risk of delayed
bleeding post lesion
resection, - Anchoring to affix
jejunal feeding tubes to
the wall of the small
bowel, - As a supplementary
method for closure of GI
tract luminal perforations
less than 20 mm that can
be treated conservatively, - Anchoring to affix fully
covered esophageal self-
expanding metal stents to
the wall of the esophagus
in patients with fistulas,
leaks, perforations, or
disunion. | • Arteries less than 2 mm,
• Polyps less than 1.5 cm
in diameter,
• Diverticula in the colon,
and
• Prophylactic clipping to
reduce the risk of delayed
bleeding post lesion
resection, - Anchoring to affix
jejunal feeding tubes to
the wall of the small
bowel, - As a supplementary
method for closure of GI
tract luminal perforations
less than 20 mm that can
be treated conservatively, - Anchoring to affix fully
covered esophageal self-
expanding metal stents to
the wall of the esophagus
in patients with fistulas,
leaks, perforations, or
disunion. | |
| Packaging | Pouch | Pouch | Identical |
| Sterilization | Ethylene Oxide | Ethylene Oxide | Identical |
| Shelf Life | 3 Years | 1 Year | Subject device is
supported for three-
year shelf life based on
the same method
described in the
previous 510(k).
Change in Shelf Life
was not the result of
device modification,
nor did the change
impact shelf life. |
| Configuration | Delivery system and clip | Delivery system and clip | Identical |
| MR
Conditional | Yes | Yes | Identical |
| | | Clip | |
| Number of
Prongs | 2 | 2 | Identical |
| Parameter | Instinct Plus Endoscopic
Clipping Device (Subject Device) | Instinct Plus Endoscopic
Clipping Device (K192697) | Comparison |
| Jaw Width | 16 mm | 16 mm | Identical |
| Clip Geometry | Cylindrical housing, rounded arms with serrated tip | Cylindrical housing, rounded arms with serrated tip | Identical |
| Number of
Open-Close
Cycles Prior to
Deployment | 5 | 5 | Identical |
| Handle
Controlled Clip
Rotation | Yes | Yes | Identical |
| Introducer | | | |
| Working
Length | 230 cm | 230 cm | Identical |
| Introducer
Diameter
(nominal) | 7 Fr | 7 Fr | Identical |
| Minimum
Working
Channel of
Endoscope | 2.8 mm for forward viewing endoscope, and
4.2 mm for side viewing endoscope | 2.8 mm for forward viewing endoscope, and
4.2 mm for side viewing endoscope | Identical |
5
Cook Endoscopy – Special 510(k) Instinct Plus Endoscopic Clipping Device
6
Cook Endoscopy – Special 510(k) Instinct Plus Endoscopic Clipping Device
Non-Clinical and/or Clinical Tests Summary and Conclusions:
Baseline testing consisting of non-clinical bench testing demonstrates that the Instinct Plus Endoscopic Clipping Device enabled consistent deployment of the clip to fulfill the intended use of the device. Validation testing was repeated to deploy devices without tissue to simulate worst case. Validation testing was also repeated utilizing process data to confirm the Strength of Distal Coil Cath Tabs met acceptance criteria. Testing passed demonstrating the device is substantially equivalent to the currently cleared predicate device.